Reaction

Aortic Valve Stenosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,766 reports · 67 co-occurring drugs

As of the last recalculation, Aortic Valve Stenosis appears in 1,766 FAERS reports alongside 67 co-occurring drug terms. The strongest observed disproportionality signal is THEOPHYLLINE ANHYDROUS (PRR 98.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Theophylline Anhydrous	98	98.6	99.4
Theophylline	89	96.1	96.8
Tamsulosin Hydrochloride	69	41.4	41.6
Amiodarone Hydrochloride	33	35.4	35.5
Fluticasone Furoate And Vilanterol Trifenatate	75	25.6	25.7
Finasteride	107	22.2	22.2
Olmesartan Medoxomil	63	21.4	21.4
Torsemide	52	19.0	19.1
Meperidine Hydrochloride	14	18.0	18.1
Bisoprolol Fumarate	187	18.0	18.0
Apixaban	97	18.0	18.0
Tolvaptan	19	15.6	15.6
Nebivolol	18	13.4	13.5
Amlodipine Besylate And Valsartan	12	12.9	12.9
Baricitinib	10	12.3	12.3
Valsartan Oral	55	12.3	12.3
Allopurinol	146	11.9	11.9
Febuxostat Tablets 40 Mg	10	11.7	11.7
Febuxostat Tablets 80 Mg	10	11.7	11.7
Clopidogrel Bisulfate	93	11.3	11.3
Pantoprazole	210	11.0	11.0
Metoprolol Succinate Er Tablets	55	10.7	10.7
Enalapril Maleate	22	10.6	10.6
Tiotropium Bromide	114	10.4	10.4
Metoprolol Succinate	72	10.2	10.2
Montelukast Sodium	99	10.1	10.1
Atropine	7	10.0	10.0
Lactulose	31	9.7	9.7
Quinine	7	9.7	9.7
Sodium Chloride	61	9.4	9.4
Candesartan	28	9.4	9.4
Montelukast	64	9.3	9.3
Aspirin 325 Mg	334	9.3	9.3
Aspirin 81 Mg	334	9.3	9.3
Sodium Chloride Tablet	56	9.2	9.2
Sodium Chloride Tablets	56	9.2	9.2
Aspirin	338	8.9	8.9
Valsartan	74	8.6	8.6
Digoxin	51	8.6	8.6
Methoxy Polyethylene Glycol-Epoetin Beta	8	8.6	8.6
Febuxostat	12	8.5	8.5
Clopidogrel	133	8.5	8.5
Epoetin Alfa	8	8.0	8.0
Amlodipine Besylate And Benazepril Hydrochloride	6	7.7	7.7
Ticagrelor	20	7.5	7.5
Isosorbide Mononitrate	13	7.4	7.4
Nebivolol Hydrochloride	21	7.4	7.4
Linagliptin	11	7.1	7.2
Diclofenac Sodium 1%	21	7.0	7.0
Diclofenac Sodium Topical	21	7.0	7.0
Diclofenac Sodium Topical Gel, 1%	21	7.0	7.0
Agalsidase Beta	5	6.4	6.4
Darbepoetin Alfa	28	6.2	6.2
Tafamidis	6	6.0	6.0
Paricalcitol	7	5.9	5.9
Norepinephrine	5	5.5	5.5
Dapagliflozin	14	5.3	5.3
Umeclidinium	4	5.3	5.3
Romosozumab-Aqqg	6	5.2	5.2
Selexipag	11	5.0	5.0
Sacubitril And Valsartan	42	4.3	4.3
Acalabrutinib	4	3.9	3.9
Mometasone Furoate And Formoterol Fumarate Dihydrate	5	3.8	3.8
Apalutamide	3	3.0	3.0
Exenatide	13	2.9	2.9
Sarilumab	6	2.7	2.7
Evolocumab	18	1.3	1.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.